Come up with a name for your new list and we'll add to it:
Organogenesis raised a round of funding on August 17, 2018. Investors include
Avista Healthcare Public Acquisition Corp..
Organogenesis provides wound care products for bio-active wound healing and soft tissue regeneration. The portfolio includes FDA-approved Apligraf and Dermagraft, for bio-active wound healing and laun…